Skip to content

Boryung Corp Sustainability Reports

Boryung Corp. develops, manufactures, and commercializes prescription and over-the-counter pharmaceuticals, specializing heavily in treatments for hypertension, oncology, and diabetes.

Sector: Manufacturing

Country: South Korea

Exchange: Korea Exchange (KOSPI)

FIGI: BBG001S71T60

4 reports from 2021 to 2024